The CEO of French consumer goods giant Danone on Wednesday downplayed the threat of obesity drugs on its food business. Antoine de Saint-Affrique told CNBC that surging demand for drugs like Wegovy ...

Parents are warned to return any of the specific product affected because it is not safe for babies to consume.

Danone is preparing litigation against kefir maker – and takeover target – Lifeway Foods, alleging the business broke a shareholder agreement between the two companies. An investor in Lifeway since ...

Danone plans to double down on health and nutrition in the coming years as food companies seek to tackle the effects of Ozempic and other blockbuster weight-loss drugs on eating habits. Two years into ...